These are the only 2 ETFs that made money every year for the past decade

Two defensive stock exchange-traded funds (ETFs) have consistently had positive returns over the past decade. The Amundi ETF MSCI Europe Healthcare UCITS ETF and the Canadian consumer staples iShares S & P/TSX Capped Consumer Staples Index ETF had profitable years from 2014 to 2023. These two funds stood out among thousands of screened equity worldwide. The Amundi health-care fund recorded its 10th consecutive year of positive returns in 2023. The performance can be attributed to pharmaceutical stocks, which make up around 80% of the MSCI Europe Healthcare Index. The stability of the health-care ETF can be explained by the defensive nature of the pharmaceutical sector and the earnings visibility offered by big pharmaceutical companies. The ETF has also benefited from currency fluctuations. Novo Nordisk, a key component of the index, has contributed to the ETF’s performance due to the success of its new anti-obesity drug. However, there are concerns that expectations for weight loss drugs may be too high. The pharma sector, excluding Novo Nordisk, is considered fairly valued with solid fundamentals. It’s worth noting that the health-care sector tends to underperform in election years, although health care and drug pricing are not expected to be major election issues this year due to the industry’s improved reputation during the COVID-19 pandemic.